Search research articles
Contact Us
Filters
Showing results (1-10 of 77) with videos related to
Page
of 8
Sort By:
Journal of Cellular Physiology
|
September 23, 2003
How the other half lives, the amino-terminal domain of the retinoblastoma tumor suppressor protein
David W Goodrich
Molecular Cancer Therapeutics
|
May 14, 2004
Different DNA lesions trigger distinct cell death responses in HCT116 colon carcinoma cells
Shaochun Bai, David W Goodrich
Frontiers in Genetics
|
April 4, 2022
Retinoblastoma Protein Paralogs and Tumor Suppression
Mauricio Flores, David W Goodrich
Current Topics in Developmental Biology
|
February 8, 2011
RB1, development, and cancer
Meenalakshmi Chinnam, David W Goodrich
International Journal of Oncology
|
February 9, 2006
Combination gene therapy with p53 and Thoc1/p84 is more effective than either single agent in an animal model of human pancreatic adenocarcinoma
Shenmin Yin, David W Goodrich
Cancer Heterogeneity and Plasticity
|
September 25, 2025
The molecular determinants of phenotypic plasticity in homeostasis and neoplasia
Bradley Balk, David W Goodrich
Oncogene
|
August 11, 2005
The retinoblastoma tumor suppressor protein is required for efficient processing and repair of trapped topoisomerase II-DNA-cleavable complexes
Hai Xiao, David W Goodrich
Genesis (New York, N.Y. : 2000)
|
December 23, 2009
Construction of a dual affinity tagged allele of the Rb1 tumor suppressor gene in the mouse
Hai Xiao, Xiaojing Zhang, David W Goodrich
Molecular & Cellular Oncology
|
April 13, 2017
Evasion of targeted cancer therapy through stem-cell-like reprogramming
Kristine M Wadosky, Leigh Ellis, David W Goodrich
Molecular and Cellular Biology
|
March 23, 2016
Evaluating Effects of Hypomorphic Thoc1 Alleles on Embryonic Development in Rb1 Null Mice
Meenalakshmi Chinnam, Xiaoling Wang, Xiaojing Zhang, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 77) with videos related to
Sort By:
Page
of 8
Journal of Cellular Physiology
|
September 23, 2003
How the other half lives, the amino-terminal domain of the retinoblastoma tumor suppressor protein
David W Goodrich
Molecular Cancer Therapeutics
|
May 14, 2004
Different DNA lesions trigger distinct cell death responses in HCT116 colon carcinoma cells
Shaochun Bai, David W Goodrich
Frontiers in Genetics
|
April 4, 2022
Retinoblastoma Protein Paralogs and Tumor Suppression
Mauricio Flores, David W Goodrich
Current Topics in Developmental Biology
|
February 8, 2011
RB1, development, and cancer
Meenalakshmi Chinnam, David W Goodrich
International Journal of Oncology
|
February 9, 2006
Combination gene therapy with p53 and Thoc1/p84 is more effective than either single agent in an animal model of human pancreatic adenocarcinoma
Shenmin Yin, David W Goodrich
Cancer Heterogeneity and Plasticity
|
September 25, 2025
The molecular determinants of phenotypic plasticity in homeostasis and neoplasia
Bradley Balk, David W Goodrich
Oncogene
|
August 11, 2005
The retinoblastoma tumor suppressor protein is required for efficient processing and repair of trapped topoisomerase II-DNA-cleavable complexes
Hai Xiao, David W Goodrich
Genesis (New York, N.Y. : 2000)
|
December 23, 2009
Construction of a dual affinity tagged allele of the Rb1 tumor suppressor gene in the mouse
Hai Xiao, Xiaojing Zhang, David W Goodrich
Molecular & Cellular Oncology
|
April 13, 2017
Evasion of targeted cancer therapy through stem-cell-like reprogramming
Kristine M Wadosky, Leigh Ellis, David W Goodrich
Molecular and Cellular Biology
|
March 23, 2016
Evaluating Effects of Hypomorphic Thoc1 Alleles on Embryonic Development in Rb1 Null Mice
Meenalakshmi Chinnam, Xiaoling Wang, Xiaojing Zhang, et al.
Page
of 8